These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6506985)
41. [Pharmacological treatment of borderline personality disorders. Several options for symptom reduction but nothing for the disorder per se]. Rydén G; Vinnars B Lakartidningen; 2002 Dec; 99(50):5088-94. PubMed ID: 12572301 [TBL] [Abstract][Full Text] [Related]
42. [Problem of the classification of borderline states]. Semke VIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(11):1673-9. PubMed ID: 3434069 [TBL] [Abstract][Full Text] [Related]
43. [Antabus is unsuitable in treatment of borderline personalities]. Aberg J Lakartidningen; 1984 Oct; 81(41):3684-5. PubMed ID: 6503477 [No Abstract] [Full Text] [Related]
44. [Personality disorder]. André C Rev Prat; 2008 Mar; 58(5):551-6; quiz 575. PubMed ID: 18524115 [No Abstract] [Full Text] [Related]
45. [A reversible functional disorder of the escape reaction as a model for studying the effect of tranquilizers]. Inozemtsev AN; Bakieva SB; Voronina TA; Tushmalova NA Eksp Klin Farmakol; 1996; 59(2):3-5. PubMed ID: 8974560 [TBL] [Abstract][Full Text] [Related]
46. [Dependence of the strength of anxiolytic effect of tranquilizers on the level of anxiety in a conflict situation]. Molodavkin GM; Voronina TA Biull Eksp Biol Med; 1996 Jan; 121(1):63-6. PubMed ID: 8680009 [No Abstract] [Full Text] [Related]
47. An open trial of valproate in borderline personality disorder. Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502 [TBL] [Abstract][Full Text] [Related]
48. [Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia]. Kadysheva NM; Mokhovikov AN; Mosketi KV; Kryzhanovskiĭ GN Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(10):88-92. PubMed ID: 2975124 [TBL] [Abstract][Full Text] [Related]
53. Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission. Zanarini MC; Frankenburg FR; Vujanovic AA; Hennen J; Reich DB; Silk KR Acta Psychiatr Scand; 2004 Dec; 110(6):416-20. PubMed ID: 15521825 [TBL] [Abstract][Full Text] [Related]
54. Pharmacotherapy for patients with borderline personality disorder. Goldberg SC; Schulz SC Arch Gen Psychiatry; 1988 Feb; 45(2):195-6. PubMed ID: 2892479 [No Abstract] [Full Text] [Related]
55. [Clinico-psychological examination of young children with borderline mental disorders of a neurotic degree]. Kozlovskaia GV; Kirichenko EI; Skoblo GV; Budareva LA Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(10):109-13. PubMed ID: 7180270 [No Abstract] [Full Text] [Related]
56. [Borderline syndrome, neuroses and personality disorders. A comparative study based on research-oriented criteria for borderline schizophrenia]. Sass H; Koehler K Nervenarzt; 1982 Sep; 53(9):519-23. PubMed ID: 7133252 [No Abstract] [Full Text] [Related]
58. [Effect of stimulation of the paleocerebellar cortex on the multifocal cortical epileptogenic complex]. Kryzhanovskiĭ GN; Makul'kin RF; Lobasiuk BA Biull Eksp Biol Med; 1981 Oct; 91(10):398-400. PubMed ID: 7317594 [TBL] [Abstract][Full Text] [Related]
59. Era-related changes in the Japanese cultural and social structure and conformist personality pathology--with a particular emphasis on borderline personality disorder. Tamai K Fukuoka Igaku Zasshi; 1997 Apr; 88(4):84-9. PubMed ID: 9154712 [TBL] [Abstract][Full Text] [Related]
60. Pharmacotherapy for patients with borderline personality disorder. Gunderson JG Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]